LEIDEN, NETHERLANDS--(Marketwire - February 22, 2011) - Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) and San Diego based specialty biopharmaceutical company Santarus, Inc.
6 analysts have expressed a variety of opinions on Pharming (NASDAQ:PHAR) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback